Covalis Capital’s M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 MBAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding MBAC.WS
AFM
RCM
CF
CC
AC
AA
CH
CCP
SCM
Covalis Capital's MBAC.WS Position: Q2 2022 in Review
Covalis Capital sold out of M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (MBAC.WS) in Q2 2022, closing a stake of 182,524 shares — an estimated $798K sold.
Covalis Capital first reported a position in MBAC.WS in Q4 2021 and held it in 2 quarters. The position peaked at $1.42M in Q4 2021. 50 funds tracked by Wall St. Rank hold MBAC.WS as of Q2 2022.
- Covalis Capital reported no remaining M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
- Covalis Capital sold 182,524 M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q2 2022, an estimated $798K.
- Covalis Capital first reported a position in M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
- Covalis Capital's M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $1.42M in Q4 2021.
- 50 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q2 2022.
Based on Covalis Capital's 13F filing for Q2 2022, filed 15 Aug 2022.